	Recorded Early Imaging Responses After Transarterial Chemoembolization Plus Lenvatinib Versus Transarterial Chemoembolization Without Documented Lenvatinib for Unresectable Hepatocellular Carcinoma: A Vietnamese Cohort Study. J Clin Med Minh VL, Hung NV, Anh PT, Anh PT, Thong PM. PMID: 42739846 [PubMed]
	Mitoxyperilysis Drives Immunosuppressive Tumor Microenvironment Remodeling and Hepatocellular Carcinoma Progression via ANXA1-Mediated Macrophage M2 Polarization. Cancers (Basel) Qin M, He W, Wu G. PMID: 42738308 [PubMed]
	Beyond Canonical Neoantigens: Emerging Technologies for Identification of Noncanonical Antigens and Implications for Personalized Cancer Vaccines. Cancers (Basel) Yang Y, Kane T, Abdelzaher AT, Goedegebuure SP, Gillanders WE. PMID: 42738301 [PubMed]
	Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcoming Pancreatic Cancer Progression and Resistance Through Supplement Therapy. Int J Mol Sci Fanijavadi S, Jensen LH. PMID: 42737789 [PubMed - indexed for MEDLINE]
	Metabolic Dysfunction and Related Dietary Exposures in Relation to Pancreatic Cancer Risk: A Review of the Evidence. Int J Mol Sci Yang J, Huang Y, Lophatananon A, Muir KR. PMID: 42737603 [PubMed - indexed for MEDLINE]
	Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy. Int J Mol Sci Yeganeh HT, Sellat M, Anis Z, Chiri R, Patnaik R, Gambhir S, Banerjee Y. PMID: 42737430 [PubMed - indexed for MEDLINE]
	The use of blood test trends in cancer detection: a scoping review. Diagn Progn Res Zhu S, Friedemann Smith C, Collins KK, Ziyenge SE, Murphy J, de Vere Hunt I, Brubert Z, Roberts N, Morris EJA, Hobbs R, Nicholson BD, Virdee PS. PMID: 42736584 [PubMed]
	Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75â€‰Years and Older With Unresectable Pancreatic Cancer. Cancer Rep (Hoboken) Ikezawa K, Imai T, Takada R, Yamai T, Fukutake N, Urabe M, Kai Y, Mukai K, Nakabori T, Ohkawa K. PMID: 42735912 [PubMed - indexed for MEDLINE]
	Pancreatic ductal adenocarcinoma: The Vision of Heracles. Cancer Cell Mota Reyes C, Goetz MR, Algül H, Dogruoez A, Falcomatà C, Gaida MM, Görgülü K, Gültekin Y, Gürcinar IH, Hasselluhn MC, Istvanffy R, Kalluri R, Kalluri VS, Kiemen A, Kim P, Lee SW, Lesina M, Yu P, Maitra A, Müller CM, Müller S, Nam D, Olive KP, Pasca Di Magliano M, Rad R, Saur D, Vander Heiden MG, Vormehr M, Wood LD, Yöndem E, Zschäpitz D, Karakas D, Friess H, Ceyhan GO, European Pancreatic Club (EPC) Pancreatic Cancer Think Tank Group, Demir IE. PMID: 42735679 [PubMed - indexed for MEDLINE]
	Neural regulation of cancer: from microenvironmental hijacking to systemic circuit co-option. Cell Oncol (Dordr) Gu Z, Ma H, Jiang GQ, Wei J. PMID: 42734679 [PubMed - indexed for MEDLINE]
	Clinicopathological differences and risk factors of early- versus late-onset pancreatic cancer: A systematic review and meta-analysis. iScience Alzoubi M, Al Jibarat R, Saleh AO, Eisa R, Al-Sha'ar HM, Alfreijat TM, Habboub J, Rashed R, Hanoun R, Alkhateeb R, Hamady Z. PMID: 42733648 [PubMed]
	Experiences of Families Supporting Patients With Refractory Cancer: An Interpretive Descriptive Study. Glob Qual Nurs Res Morishita J, Tamura R, Shigeta R, Yatomi Y. PMID: 42733430 [PubMed]
	Converging endoscopic techniques and artificial intelligence for diagnosis and risk stratification of pancreatic cystic neoplasms. Chin Med J (Engl) Guo Y, Li X, Xie X, Liao X, Wang C, Wang R. PMID: 42733303 [PubMed - as supplied by publisher]
	The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer. Ann Surg Oncol Schaefer ML, Tsai S, Blair AB. PMID: 42732021 [PubMed - as supplied by publisher]
	Clinicopathologic Outcomes After Resection of Suspected High-Grade Pancreatic Intraepithelial Neoplasia Without Invasive Carcinoma: A Multicenter Retrospective Study. Ann Surg Oncol Mizumoto T, Nanno Y, Ishida J, Ami K, Yamane K, Uchida Y, Takahara T, Nagai K, Matsumoto I, Fukumoto T. PMID: 42732020 [PubMed - as supplied by publisher]
	AISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omic analyses in pancreatic cancer. Dig Liver Dis Cappello P, Gentiluomo M, Giovannetti E, Lonardo E, Luchini C, Marchesi F, Carnaghi C, Paiella S, Carrara S. PMID: 42731958 [PubMed - as supplied by publisher]
	Deep learning-based CT model for non-invasive prediction of tertiary lymphoid structures in pancreatic cancer: a multicenter study with prospective validation in an immunochemotherapy cohort. J Immunother Cancer Yu H, Li X, Cheng X, Deng Y, Wang Y, Li Y, Liu B, Huang Z, Cao D. PMID: 42731878 [PubMed - indexed for MEDLINE]
	Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi-Omics and Machine Learning. FASEB J Liu X, Li Y, Qin F, Ou J. PMID: 42730913 [PubMed - indexed for MEDLINE]
	Overcoming cancer resistance in pancreatic cancer: toward dynamic precision oncology. Mol Biol Rep Okabayashi T, Tabuchi M, Tokumaru T, Uemura S, Tamura S. PMID: 42730833 [PubMed - indexed for MEDLINE]
	Mesenchymal Neoplasms of the Pancreatobiliary Tract. Arch Pathol Lab Med Agostini-Vulaj D. PMID: 42730539 [PubMed - as supplied by publisher]

Articles 1 - 20 / 61509

Page 1 of 3076



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy